Literature DB >> 29728831

Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure.

Pere Llorens1, Patricia Javaloyes1, Francisco Javier Martín-Sánchez2,3, Javier Jacob4, Pablo Herrero-Puente5, Víctor Gil6, José Manuel Garrido7, Eva Salvo8, Marta Fuentes9, Héctor Alonso10, Fernando Richard11, Francisco Javier Lucas12, Héctor Bueno13,14, John Parissis15, Christian E Müller16, Òscar Miró17,18,19.   

Abstract

OBJECTIVES: To analyse time trends in patient characteristics, clinical course, hospitalisation rate, and outcomes in acute heart failure along a 10-year period (2007-2016).
METHODS: The EAHFE registry has prospectively collected 13,971 consecutive AHF patients diagnosed in 41 Spanish emergency departments (EDs) at five different time points (2007/2009/2011/2014/2016). Eighty patient-related variables and outcomes were described and statistically significant changes along time were evaluated. We also compared our data with large ED- and hospital-based registries.
RESULTS: Compared to other large registries, our patients were older [80 (10) years], more frequently women (55.5%), and had a higher prevalence of hypertension (83.5%) and a lower prevalence of ischaemic cardiomyopathy (29.4%). De novo AHF was observed in 39.6%. 63.6% showed some degree of functional dependence and 56.1% had preserved left ventricular ejection fraction (LVEF). 56.8% of the patients arrived at the ED by ambulance, 4.5% arrived hypotensive, and 21.3% hypertensive. Direct discharge from the ED home was seen in 24.9%, and internal medicine (32.5%) and cardiology (15.8%) were the main hospital destinations. Triggers for decompensation were identified in 75.4%, the most being frequent infection (35.2%) and rapid atrial fibrillation (14.7%). The AHF phenotypes were: warm/wet 82.0%, warm/dry 6.2%, cold/wet 11.1%, and cold/dry 0.7%. The length of hospitalisation was 9.3 (8.6) days, and in-hospital, 30-day, and 1-year all-cause mortality were 7.8, 10.2 and 30.3%, respectively; and 30-day re-hospitalisation and ED revisit due to AHF were 16.9 and 24.8%, respectively. Thirty-nine of the eighty characteristics studied showed significant changes over time, while all outcomes remained unchanged along the 10-year period.
CONCLUSIONS: The EAHFE Registry is the first European ED-based registry describing the characteristics, clinical course, and outcomes of a cohort resembling the universe of patients with AHF. Significant changes were observed over time in some aspects of AHF characteristics and management, but not in outcomes.

Entities:  

Keywords:  Acute heart failure; Epidemiology; Mortality; Outcome; Registry

Mesh:

Year:  2018        PMID: 29728831     DOI: 10.1007/s00392-018-1261-z

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  26 in total

1.  Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.

Authors:  Markku S Nieminen; Michael Böhm; Martin R Cowie; Helmut Drexler; Gerasimos S Filippatos; Guillaume Jondeau; Yonathan Hasin; José Lopez-Sendon; Alexandre Mebazaa; Marco Metra; Andrew Rhodes; Karl Swedberg; Silvia G Priori; Maria Angeles Alonso Garcia; Jean-Jacques Blanc; Andrzej Budaj; Martin R Cowie; Veronica Dean; Jaap Deckers; Enrique Fernandez Burgos; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; João Morais; Ali Oto; Otto A Smiseth; Maria Angeles Alonso Garcia; Kenneth Dickstein; Anibal Albuquerque; Pedro Conthe; Maria Crespo-Leiro; Roberto Ferrari; Ferenc Follath; Antonello Gavazzi; Uwe Janssens; Michel Komajda; João Morais; Rui Moreno; Mervyn Singer; Satish Singh; Michal Tendera; Kristian Thygesen
Journal:  Eur Heart J       Date:  2005-01-28       Impact factor: 29.983

2.  [Prehospital emergency care of patients with acute heart failure in Spain: the SEMICA study (Emergency Medical Response Systems for Patients with Acute Heart Failure)].

Authors:  Òscar Miró; Pere Llorens; Xavier Escalada; Pablo Herrero; Javier Jacob; Víctor Gil; Carolina Xipell; Carolina Sánchez; Sira Aguiló; Francisco J Martín-Sánchez
Journal:  Emergencias       Date:  2017-07       Impact factor: 3.881

3.  Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

Authors:  John R Teerlink; Gad Cotter; Beth A Davison; G Michael Felker; Gerasimos Filippatos; Barry H Greenberg; Piotr Ponikowski; Elaine Unemori; Adriaan A Voors; Kirkwood F Adams; Maria I Dorobantu; Liliana R Grinfeld; Guillaume Jondeau; Alon Marmor; Josep Masip; Peter S Pang; Karl Werdan; Sam L Teichman; Angelo Trapani; Christopher A Bush; Rajnish Saini; Christoph Schumacher; Thomas M Severin; Marco Metra
Journal:  Lancet       Date:  2012-11-07       Impact factor: 79.321

4.  Diuretic strategies in patients with acute decompensated heart failure.

Authors:  G Michael Felker; Kerry L Lee; David A Bull; Margaret M Redfield; Lynne W Stevenson; Steven R Goldsmith; Martin M LeWinter; Anita Deswal; Jean L Rouleau; Elizabeth O Ofili; Kevin J Anstrom; Adrian F Hernandez; Steven E McNulty; Eric J Velazquez; Abdallah G Kfoury; Horng H Chen; Michael M Givertz; Marc J Semigran; Bradley A Bart; Alice M Mascette; Eugene Braunwald; Christopher M O'Connor
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

5.  EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.

Authors:  Markku S Nieminen; Dirk Brutsaert; Kenneth Dickstein; Helmut Drexler; Ferenc Follath; Veli-Pekka Harjola; Matthias Hochadel; Michel Komajda; Johan Lassus; Jose Luis Lopez-Sendon; Piotr Ponikowski; Luigi Tavazzi
Journal:  Eur Heart J       Date:  2006-09-25       Impact factor: 29.983

6.  Risk stratification in women enrolled in the Acute Decompensated Heart Failure National Registry Emergency Module (ADHERE-EM).

Authors:  Deborah B Diercks; Gregg C Fonarow; J Douglas Kirk; Charles L Emerman; Judd E Hollander; Jim Edward Weber; Richard L Summers; Janet Wynne; W Franklin Peacock
Journal:  Acad Emerg Med       Date:  2008-02       Impact factor: 3.451

7.  Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome.

Authors:  Fabrizio Oliva; Andrea Mortara; Giuseppe Cacciatore; Alessandra Chinaglia; Andrea Di Lenarda; Marco Gorini; Marco Metra; Michele Senni; Aldo P Maggioni; Luigi Tavazzi
Journal:  Eur J Heart Fail       Date:  2012-07-25       Impact factor: 15.534

8.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

Authors:  J G F Cleland; K Swedberg; F Follath; M Komajda; A Cohen-Solal; J C Aguilar; R Dietz; A Gavazzi; R Hobbs; J Korewicki; H C Madeira; V S Moiseyev; I Preda; W H van Gilst; J Widimsky; N Freemantle; Joanne Eastaugh; J Mason
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

9.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

10.  Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

Authors:  Alan Maisel; Sean-Xavier Neath; Judd Landsberg; Christian Mueller; Richard M Nowak; W Frank Peacock; Piotr Ponikowski; Martin Möckel; Christopher Hogan; Alan H B Wu; Mark Richards; Paul Clopton; Gerasimos S Filippatos; Salvatore Di Somma; Inder Anand; Leong L Ng; Lori B Daniels; Robert H Christenson; Mihael Potocki; James McCord; Garret Terracciano; Oliver Hartmann; Andreas Bergmann; Nils G Morgenthaler; Stefan D Anker
Journal:  Eur J Heart Fail       Date:  2012-02-02       Impact factor: 15.534

View more
  11 in total

1.  Diagnostic and prognostic value of plasma volume status at emergency department admission in dyspneic patients: results from the PARADISE cohort.

Authors:  Tahar Chouihed; Patrick Rossignol; Adrien Bassand; Kévin Duarte; Masatake Kobayashi; Déborah Jaeger; Sonia Sadoune; Aurélien Buessler; Lionel Nace; Gaetan Giacomin; Thibaut Hutter; Françoise Barbé; Sylvain Salignac; Nicolas Jay; Faiez Zannad; Nicolas Girerd
Journal:  Clin Res Cardiol       Date:  2018-10-28       Impact factor: 5.460

2.  Time-pattern of adverse outcomes after an infection-triggered acute heart failure decompensation and the influence of early antibiotic administration and hospitalisation: results of the PAPRICA-3 study.

Authors:  Òscar Miró; Koji Takagi; Étienne Gayat; Víctor Gil; Pere Llorens; Francisco J Martín-Sánchez; Javier Jacob; Pablo Herrero-Puente; Rosa Escoda; María Pilar López-Díez; Amparo Valero; Marta Fuentes; José M Garrido; Eva Salvo; Miguel A Rizzi; Alfons Aguirre; Lissete Travería Bécquer; Alberto Domínguez-Rodríguez; Joan Padrosa; Gemma Martínez; Mattia Arrigo; Yonathan Freund; Alexandre Mebazaa
Journal:  Clin Res Cardiol       Date:  2019-04-29       Impact factor: 5.460

3.  Ambient temperature and atmospheric pressure at discharge as precipitating factors in immediate adverse events in patients treated for decompensated heart failure.

Authors:  Miguel Benito-Lozano; Pedro López-Ayala; Sergio Rodríguez; Víctor Gil; Pere Llorens; Ana Yufera; Javier Jacob; Lissete Travería-Becker; Ivo Strebel; Francisco Javier Lucas-Imbernon; Josep Tost; Ángeles López-Hernández; Beatriz Rodríguez; Marta Fuentes; Susana Sánchez-Ramón; Sergio Herrera-Mateo; Alfons Aguirre; M Isabel Alonso; José Pavón; M Luisa López-Grima; Begoña Espinosa; Christian Mueller; Guillermo Burillo-Putze; Òscar Miró
Journal:  Intern Emerg Med       Date:  2022-09-01       Impact factor: 5.472

4.  Impact of diabetes and on-arrival hyperglycemia on short-term outcomes in acute heart failure patients.

Authors:  Josep Masip; Marina Povar-Echeverría; William Frank Peacock; Javier Jacob; Víctor Gil; Pablo Herrero; Pere Llorens; Aitor Alquézar-Arbé; Carolina Sánchez; Francisco Javier Martín-Sánchez; Òscar Miró
Journal:  Intern Emerg Med       Date:  2022-03-29       Impact factor: 5.472

5.  Risk stratification scores for patients with acute heart failure in the Emergency Department: A systematic review.

Authors:  Òscar Miró; Xavier Rossello; Elke Platz; Josep Masip; Danielle M Gualandro; W Frank Peacock; Susanna Price; Louise Cullen; Salvatore DiSomma; Mucio Tavares de Oliveira; John Jv McMurray; Francisco J Martín-Sánchez; Alan S Maisel; Christiaan Vrints; Martin R Cowie; Héctor Bueno; Alexandre Mebazaa; Christian Mueller
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2020-08

6.  The FAST-FURO study: effect of very early administration of intravenous furosemide in the prehospital setting to patients with acute heart failure attending the emergency department.

Authors:  Òscar Miró; Pia Harjola; Xavier Rossello; Víctor Gil; Javier Jacob; Pere Llorens; Francisco Javier Martín-Sánchez; Pablo Herrero; Gemma Martínez-Nadal; Sira Aguiló; María Luisa López-Grima; Marta Fuentes; José María Álvarez Pérez; Esther Rodríguez-Adrada; María Mir; Josep Tost; Lluís Llauger; Frank Ruschitzka; Veli-Pekka Harjola; Wilfried Mullens; Josep Masip; Ovidiu Chioncel; W Frank Peacock; Christian Müller; Alexandre Mebazaa
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2021-06-30

7.  Acute Heart Failure in the 2021 ESC Heart Failure Guidelines: a scientific statement from the Association for Acute CardioVascular Care (ACVC) of the European Society of Cardiology.

Authors:  Josep Masip; W Frank Peacok; Mattia Arrigo; Xavier Rossello; Elke Platz; Louise Cullen; Alexandre Mebazaa; Susanna Price; Héctor Bueno; Salvatore Di Somma; Mucio Tavares; Martin R Cowie; Alan Maisel; Christian Mueller; Òsar Miró
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2022-02-08

8.  Does rhythm matter in acute heart failure? An insight from the British Society for Heart Failure National Audit.

Authors:  Simon G Anderson; Ahmad Shoaib; Phyo Kyaw Myint; John G Cleland; Suzanna M Hardman; Theresa A McDonagh; Henry Dargie; Bernard Keavney; Clifford J Garratt; Mamas A Mamas
Journal:  Clin Res Cardiol       Date:  2019-04-08       Impact factor: 5.460

9.  Prediction of short-term mortality in acute heart failure patients using minimal electronic health record data.

Authors:  Ashwath Radhachandran; Anurag Garikipati; Nicole S Zelin; Emily Pellegrini; Sina Ghandian; Jacob Calvert; Jana Hoffman; Qingqing Mao; Ritankar Das
Journal:  BioData Min       Date:  2021-03-31       Impact factor: 2.522

10.  Mode of presentation and mortality amongst patients hospitalized with heart failure? A report from the First Euro Heart Failure Survey.

Authors:  Ahmad Shoaib; M Farag; J Nolan; A Rigby; A Patwala; M Rashid; C S Kwok; R Perveen; A L Clark; M Komajda; J G F Cleland
Journal:  Clin Res Cardiol       Date:  2018-10-25       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.